We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Liver Enzyme Monitoring in Patients Treated With Troglitazone.
- Authors
Graham, David J.; Drinkard, Carol R.; Shatin, Deborah; Yi Tsong; Burgess, Margaret J.
- Abstract
Presents a study to evaluate the effect of the United States Food and Drug Administration (FDA) risk management efforts, including repeated labeling charges and 'Dear Healthcare Professional' letters, on liver enzyme monitoring of patients taking troglitazone. Context, including the removal of troglitazone from the market; Objective; Design, setting, and participants; Main outcome measures; Results; Conclusions.
- Subjects
UNITED States; PATIENT monitoring; UNITED States. Food &; Drug Administration; RISK management in business; DRUG monitoring
- Publication
JAMA: Journal of the American Medical Association, 2001, Vol 286, Issue 7, p831
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.286.7.831